Luqa Pharmaceuticals To Participate At Bio€quity Europe 2015
Shanghai (P.R.China) April 17, 2015 – Luqa Pharmaceuticals today announced its attendance to Bio€quity Europe 2015. The conference will be held in Vienna, Austria on May 19-20, 2015 and Luqa’s CEO, Robert Braithwaite will participate on a panel with focus on China.
The panel “The China Bridge – How Europe is Amplifying its Innovation through China Deal-Making” will start on May, 20th at 11:45am and will be moderated by Dr. Debra Yu, Managing Director of Labrador Advisors. The panelists will discuss how European companies and academia are leveraging cross-border opportunities for innovation through well established Chinese pharmaceutical companies.
May 20, 11:45-12:40 The China Bridge – How Europe is Amplifying its Innovation through China Deal-Making
Moderator, Dr. Debra Yu, Managing Director, Labrador Advisors
Dr. Benjamin Li, CEO, Lee’s Pharma
Dr. Xiaoming Zou, CBO, Eddingpharm
Dr. Mirko Scherer/Dr. Hubert Birner, TVM (invited)
Mr. Robert Braithwaite, Luqa Pharmaceuticals
Bio€quity Europe pioneered the turf-neutral concept, creating an open door for all members of the financial community and business development and licensing professionals to do business with independently selected Presenting Companies.
Now celebrating its 16th meeting, Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. Bio€quity Europe has showcased more than 700 leading European companies to thousands of investment and pharma business development professionals. Delegates from over 20 nations attended Bio€quity Europe last year.
Luqa Pharmaceuticals is a China-focused company. We acquire, develop and commercialize innovative healthcare products that bring added value to prescribers and other healthcare providers while enhancing quality of life for patients. Since its inception in 2010, Luqa has become a fast-growing revenue generating company with a broad product portfolio and pipeline. We aim to become a leader in specialty care segments in China. Please visit us at www.luqapharma.com.